Latest Cost Savings News

Way2VAT has posted a record quarterly revenue of A$1.49 million in Q4 FY24, driving a 43% increase in full-year revenue to A$4.72 million. The fintech continues to expand its enterprise client base and implement cost reductions to support future growth.

Aumake Limited reported a remarkable 239% increase in quarterly cash receipts, driven by a $16 million purchase order from Yangtze River and a strategic capital raise, positioning the company for robust growth in 2025.

Lark Distilling Co. Ltd reported a 7% increase in net sales revenue for Q2FY25, driven by strong growth in direct-to-consumer, global travel retail, and export channels despite domestic B2B challenges. The company is advancing its brand restage and maintaining solid cash reserves.

Articore Group reveals a strategic restructure delivering significant cost savings and improved margins, even as marketplace revenue continues to decline. The launch of a new product, Dashery, aims to diversify revenue streams.

MedAdvisor Limited reported a significant 38.6% drop in 2Q FY25 revenue due to vaccine program deferrals but expects a stronger second half driven by a diversified US pipeline and cost-saving initiatives.

Universal Biosensors is expanding its handheld testing portfolio with the upcoming AQUASCOUT water sensor and growing sales of its FDA-approved Xprecia Prime blood coagulation device, targeting multi-billion-dollar markets.

PlaySide Studios reports a 21% revenue decline in 1HFY25 and revises full-year guidance downward, citing slower Work for Hire contracts and underperforming original IP sales. Despite short-term challenges, the company remains bullish on upcoming game launches.

DY6 Metals reports encouraging metallurgical sampling results at its Tundulu rare earths project alongside strategic cost reductions and a successful loyalty options offer, positioning the company for focused exploration in Malawi.

Zoom2u Technologies reported a 5% increase in Q2 FY25 revenue to $1.66 million, alongside a modest EBITDA loss of $29,000. The company also adopted a new Treasury Management Policy to accept Bitcoin payments, signaling strategic innovation.

Burgundy Diamond Mines reported a dip in Q4-2024 production and revenue amid operational transitions but maintains a bullish outlook for 2025 driven by strategic mine development and market recovery.

OncoSil Medical has achieved a key regulatory milestone with MDR certification from BSI, removing post-market restrictions and streamlining its commercial operations across Europe. This approval also paves the way for renewed efforts to enter the Australian market.

Hawsons Iron Limited is progressing key process optimisation initiatives focused on dry crushing circuits and by-product extraction, while deepening government and investor engagement to enhance the Hawsons Iron Project’s value.